Contractors / Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
prime recipient of federal awards · UEI FCFDA78HKKG2 ✓ from source
$2.9B
obligated · FY2025
3
funding agencies
100%
from Health and Hum…
5
states
3
industries
Obligations by year
≈ computed$1.9B
FY20
$2.8B
FY21
$3.1B
FY22
$2.1B
FY23
$2.9B
FY24
$2.9B
FY25
▲ 52%
since FY20
Where this money comes from
✓ from sourceFUNDING AGENCIES
MERCK SHARP & DOHME LLC
HHS
$2.9B
2 other agencies
$0B
Merck Sharp & Dohme LLC
$2.9B
FY2025 obligated
Biggest awards (total value)
awarded 2021$2.2B
awarded 2014$1.5B
awarded 2017$1.5B
awarded 2013$1.4B
awarded 2012$1.4B
awarded 2011$1.3B
awarded 2017$236.3M
awarded 2024$155.8M
Total value over each award’s life, for awards active in FY2025: a decades-long contract can exceed one year’s obligations above.
What it does (NAICS / PSC)
Where the work lands
New Jersey✓ from source$4.1M
Tennessee✓ from source$725.5K
Texas✓ from source$573.3K
Pennsylvania✓ from source$15K
Competitors
Mckesson Corporation≈ computed$11.9B
Sanofi Vaccines US Inc.≈ computed$1B
Glaxosmithkline, LLC≈ computed$958.8M
Pfizer Inc≈ computed$700.6M
Alvogen, Inc.≈ computed$227.7M
Bavarian Nordic A/S≈ computed$143.6M
DMS Pharmaceutical Group Inc≈ computed$4.3M
Baylor College of Medicine≈ computed$3.1M
computed from shared NAICS, not a stated rivalry.
Corporate family
Single registration: no combined family.
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.